Close Menu

NEW YORK — Nicoya said on Tuesday that it has been awarded up to C$299,190 ($220,963) from the National Research Council of Canada Industrial Research Assistance Program to develop a portable, saliva-based SARS-CoV-2 test.

Called Atlas, the test will comprise a smartphone-powered single-use, disposable device that detects active SARS-CoV-2 infection based on the presence of viral proteins, with results available in less than 20 minutes, according to the Ontario-based company.

Nicoya said that development of an Atlas prototype is underway.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.